OTLK · Outlook Therapeutics, Inc.

Summary

Outlook Therapeutics, Inc. filed an 8-K on March 11, 2026, disclosing the resignation of Dr. Julia Haller effective March 6, 2026, under Item 5.02, with her resignation letter attached as Exhibit 99.1. This executive departure may impact leadership continuity.

Key takeaways

• Dr. Julia Haller resigned effective March 6, 2026.
• Resignation letter dated March 6, 2026, filed as Exhibit 99.1.
• Disclosure under Item 5.02: Departure of Directors or Certain Officers.
• Filing date: March 11, 2026.